The phenomenon of antagonism between components of the classical NFκB pathway and p53 has been studied in a number of experimental systems27, including direct demonstration that p53 suppression leads to increased p65 activity in cancer cells29, 41. The gene discussed is NFKB1; the disease is cancer.